ATXI (Avenue Therapeutics Inc.) Sof foyda

ATXI (Avenue Therapeutics Inc.) - kompaniyaning tovar belgisi

Avenue Therapeutics (ATXI) jarrohlik amaliyotlariga intravena og'riqni boshqarish agentlarini joriy qilish orqali yopiq terapevtik zanjirni yaratmoqda. Kompaniyaning quyidagi grafikdagi moliyaviy natijalari tushumlar dinamikasini aks ettiradi, bunda 0.00 parametrning joriy holatini belgilaydi. Kritik holatlar uchun ishlab chiqilayotgan vositalar iqtisodiy tendentsiyalardan mustaqil bo'lib, buning o'rniga tartibga soluvchi organlarning qarorlariga tayanadi. Sotuvlarning yo'qligi va joriy klinik sinov bosqichi emitentni narxlarni belgilash imkoniyatidan mahrum qilmoqda.

ATXI: Avenue Therapeutics, Inc. Sof foyda 04.07.2022 - 29.03.2025

Avenue Therapeutics, Inc. (ATXI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Avenue Therapeutics Inc|ATXI - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Avenue Therapeutics Inc|ATXI - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Avenue Therapeutics|ATXI - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti avenuetx.com|ATXI - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Avenue Therapeutics|ATXI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|ATXI - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Avenue Therapeutics Inc|ATXI - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Avenue Therapeutics|Oraliq likvidlik koeffitsiyenti avenuetx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ATXI - Sof foyda
Fundamental baholash:ATXI Avenue Therapeutics Inc
Avenue Therapeutics, Inc. brendining mahsuloti

Biotehnologiya sektoridagi fundamental yetakchilarni aniqlash uchun tahlilchilar sof foyda generatsiyasi tendentsiyalarini baholaydilar, bu esa savdo faoliyatining keskin oshishi davrida narxlar dinamikasining haqiqiy barqarorligini tasdiqlaydi. Ushbu ko'rsatkichning o'sishi Markaziy Nerv Tizimi (CNS) dori vositalari va Tramadol IV ning tijorat muvaffaqiyatini aks ettiradi, Avenue Therapeutics (ATXI) ning joriy foyda darajalari esa FDA tasdig'idan oldin organik bozor kengayishini spekulyativ xatarlardan ajratish imkonini beradi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof foyda regencellbioscience.com|Sof daromad AXSM (Axsome Therapeutics, Inc.)|Kompaniyaning sof foydasi ACAD (ACADIA Pharma)|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Kompaniyaning sof daromadi|SUPN - Kompaniyaning sof foydasi|CPRX (catalystpharma.com) - Kompaniya foydasi|DNLI (Denali Therapeutics Inc.) - Sof daromad|Harmony Biosciences Inc (HRMY) - Sof foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|Kompaniyaning sof daromadi Amylyx Corp AMLX|Sof daromad TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Yakuniy foyda|Anavex Life Sciences Corp. - Sof daromad|Soliqlar to‘langandan keyingi foyda CBLL (CeriBell Inc)|Prothena Biosciences - Sof foyda|Yakuniy foyda ALEC (Alector, Inc.)|ANNX: Sof foyda|Kompaniyaning sof daromadi Omeros (OMER)|Kompaniyaning sof foydasi Neurogene|ACIU: Yakuniy foyda|Sof foyda VYGR|Sof foyda Neumora Corp (NMRA)|Kompaniyaning sof foydasi Scilex Holding Company SCLX|TVGN (tevogen.com) - Soliqdan keyingi foyda|Alpha Cognition Corp - Sof foyda|Kompaniyaning sof daromadi cogrx.com|IKT (Inhibikase) - Sof daromad|Cassava Pharma (SAVA) - Sof foyda|Sof daromad ASRT|COYA (Coya) - Soliqlar to‘langandan keyingi foyda|Sof foyda VTGN|Sof moliyaviy natija ovidrx.com|Sof foyda ABOS (Acumen Pharma)|CRVO - Sof daromad|ATHE - Kompaniyaning sof foydasi|Sof moliyaviy natija Clene Inc. CLNN|PEPG: Sof foyda|jupiterneurosciences.com (JUNS) - Sof foyda|Sof daromad RLMD|ANVS (Annovis Bio Corporation) - Soliqlar to‘langandan keyingi foyda|Sof daromad GRCE (Grace Therapeutics, Inc.)|fireflyneuro.com - Kompaniya foydasi|Sof foyda KLTO (Klotho Neurosciences)|Sof moliyaviy natija NeuroSense Therapeutics Ltd (NRSN)|RVPH - Kompaniyaning sof foydasi|MTVA (MetaVia Inc) - Kompaniya foydasi|NRXS: Sof foyda|Kompaniyaning sof daromadi Helius Medical Technologies (HSDT)|Sof daromad PASG|Sof foyda Neuphoria|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|ATHA (Athira Pharma Corp) - Yakuniy foyda|Kompaniyaning sof foydasi Addex Therapeutics ADXN|Alzamend Neuro Inc. (ALZN) - Kompaniyaning sof daromadi|Cyclerion - Sof foyda|PTIX - Sof foyda|KTTA (pasitheaclinics.com) - Sof daromad|CRGT (Cortigent) - Kompaniyaning sof foydasi|BCLI (Brainstorm Cell) - Sof foyda|Kompaniyaning sof daromadi caratherapeutics.com CARA|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Kompaniya foydasi|Intra-Cellular Therapies, Inc. - Sof daromad|Sof foyda Longboard LBPH|Marinus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi nkgenbiotech.com|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|Sage Therapeutics Inc. - Yakuniy foyda|Sof daromad SNPX|TRVN (Trevena Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda VIGL|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)